Shares of Stellantis NV (STLAM.IT) and Volkswagen AG (VOW1.DE) lost value in this week's final trading session, as some of their plug-in cars lost access to U.S. tax credits under stricter regulations that went into effect this week. The VW ID.4 crossover lost its full $7,500 tax credit, according to the latest list from the Department of Energy and the Environmental Protection Agency. Some Stellantis models also ceased to qualify for the credits.
What's more, Stellantis passenger car production at its Italian plants fell to 283,090 vehicles in 2024 (down 45.7% year-on-year), the lowest since 1956, according to data from the FIM-CISL labor union.
Automotive stocks are once again under pressure from the supply side. Source: xStation
J.B. Hunt gains 18% after strong quarterly results 🚀
Stock of the Week - Lam Research Corp (16.10.2025)
Salesforce surges 8% amid positive long-term revenue forecast📈
Thermo Fisher Scientific announces strategic collaboration with OpenAI📱
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
